A major fertility company has agreed to pay $56 million after admitting to destroying embryos influenced by faulty genetic screening.
Monash IVF patients claimed 35 per cent of the embryos found to be abnormal by the flawed non-invasive test, were actually normal and could have potentially resulted in viable pregnancies.
The lawsuit is considered one of the largest class action lawsuits for negligence against an IVF provider.
READ MORE: Passenger arrested after opening emergency exit upon arrival at Melbourne Airport
More than 700 patients across the country were involved in the class action.
Margalit Injury Lawyers managing principal Michel Margalit said the settlement would finally bring some sense of justice for her clients.
"If these remarkable women and men had not brought this class action Monash IVF's secret would have remained hidden,'' Margalit said.
"The wellbeing of patients should be at the forefront of any IVF providers framework."
Lawyers said patients went on to make life-altering decisions, based on the results of the non-invasive testing regime.
It was also alleged after receiving inaccurate medical advice, many patients underwent unnecessary additional IVF treatment that may not have been necessary.
"No amount of money can ever fully compensate for the grief and mental anguish, but this settlement does send a clear message to all corporate giants putting profits before their patients that they will be found out and there will be significant consequences for such conduct,'' Margalit said.
The class action members come from Victoria, New South Wales, ACT, Northern Territory, Tasmania, Queensland and South Australia.